News related to Gamimune N (Immune Globulin) and/or conditions it is approved for
FDA Okays 20% Skin-Injection Immunodeficiency Treatment Source: MedPage Today Product Alert [2010.03.07] WASHINGTON (MedPage Today) -- The FDA has approved a new primary immunodeficiency treatment, Immune Globulin Subcutaneous 20% Liquid (Hizentra), as a once-weekly replacement therapy.